Design and Synthesis of Isosteviol Triazole Conjugates for Cancer Therapy
AbstractOne of the keys for successfully developing drugs against the broad spectrum of cancer cell types is structural diversity. In the current study, we focused on a family of isosteviol derivatives as potential novel antitumor agents. Isosteviol is a tetracyclic diterpenoid obtained by acid hydrolysis of steviol glycoside extracts isolated from abundant Stevia rebaudiana plants. In this work, we have designed and synthesized a panel of isosteviol triazole conjugates using “click” chemistry methodology. Evaluation of these compounds against a series of cancer cell lines derived from primary and metastatic tumors demonstrated that these conjugates exhibit cytotoxic activities with IC50 in the low μM range. In addition, their anti-proliferative activities are cancer cell type specific. Taken together, our studies underscore the importance of structural diversity in achieving cancer cell type specific drug development. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 1516 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Khaybullin, R.N.; Zhang, M.; Fu, J.; Liang, X.; Li, T.; Katritzky, A.R.; Okunieff, P.; Qi, X. Design and Synthesis of Isosteviol Triazole Conjugates for Cancer Therapy. Molecules 2014, 19, 18676-18689.
Khaybullin RN, Zhang M, Fu J, Liang X, Li T, Katritzky AR, Okunieff P, Qi X. Design and Synthesis of Isosteviol Triazole Conjugates for Cancer Therapy. Molecules. 2014; 19(11):18676-18689.Chicago/Turabian Style
Khaybullin, Ravil N.; Zhang, Mei; Fu, Junjie; Liang, Xiao; Li, Tammy; Katritzky, Alan R.; Okunieff, Paul; Qi, Xin. 2014. "Design and Synthesis of Isosteviol Triazole Conjugates for Cancer Therapy." Molecules 19, no. 11: 18676-18689.